参考文献
［1］ Schuster R，et al.Criteria for diagnostic and therapeutic methods of vascular embolization（kidneys，spleen，liver）（author's transl）［J］.Rontgenblatter，1982，35（4）：139-145.
［2］ Bengmark S，Andrén-Sandberg A.Infusion chemotherapy in inoperable pancreatic carcinoma［J］.Recent Results Cancer Res，1983，86：13-14.
［3］ Hasegawa H，Nimura Y，Hayakawa N，et al.Palliative treatment for unresectable cases of pancreatic carcinoma［J］.Nihon Geka Gakkai Zasshi，1985，86（12）：1625-1631.
［4］ Edge SB，Compton CC.The american joint committee on cancer：the 7th edition of the AJCC cancer staging manual and the future of TNM［J］.Annals of Surgical Oncology，2010，17（6）：1471-1474.
［5］ Tempero MA，Arnoletti JP，Behrman SW，et al.Pancreatic adenocarcinoma，version 2.2012：featured updates to the NCCN Guidelines［J］.Journal of the National Comprehensive Cancer Network Jnccn，2012，10（6）：703.
［6］ Schachter P，Avni Y，Gvirz G.The impact of laparoscopy and laparoscopic ultrasound on the management of pancreatic cystic lesions［J］.Arch Surg，2000，135（3）：260-264.
［7］ Hidagom M.Pancreatic cancer［J］.N Engl J Med，2010，362（17）：1605-1617.
［8］ Nimura Y，Nagino M，Takao S，et al.Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas［J］.J Hepatobiliary Pancreat Sci，2012，19（3）：230-241.
［9］ Jang JY，Kang MJ，Heo JS，et al.A prospective randomized controlled study comparing outcomes of standard resection and extended resection，including dissection of the nerve plexus and various lymph nodes，in patients with pancreatic head cancer［J］.Ann Surg，2014，259（4）：656-664.
［10］ Siegel R，Ma J，Zou Z，et al.Cancer statistics［J］.CA Cancer J Clin，2014，64（1）：9-29.
［11］ Hurria A，Wildes T，Blair SL，et al.Senior adult oncology，version 2.2014：clinical practice guidelines in oncology［J］.Journal of the National Comprehensive Cancer Network Jnccn，2014，12（1）：82-126.
［12］ Tol JAM，Gouma DJ，Bassi C，et al.Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma：a consensus statement by the International Study Group on Pancreatic Surgery（ISGPS）［J］.Surgery，2014，156（3）：591-600.
［13］ Bockhorn M，Uzunoglu FG，Adham M，et al.Borderline resectable pancreatic cancer：a consensus statement by the International Study Group of Pancreatic Surgery（ISGPS）［J］.Surgery，2014，155（6）：977-988.
［14］ Hartwig W，Vollmer CM，Fingerhut A，et al.Extended pancreatectomy in pancreatic ductal adenocarcinoma：definition and consensus of the International Study Group for Pancreatic Surgery（ISGPS）［J］.Surgery，2014，156（1）：1-14.
［15］ Asbun HJ，Conlon K，Fernandez-Cruz L，et al.When to performa pancreatoduodenectomy in the absence of positive histology？A consensus statement by the International Study Group of Pancreatic Surgery［J］.Surgery，2014，155（5）：887-892.
［16］ 马彦寿，李焕祥，吕峰泉，等.超选择性动脉灌注及栓塞治疗晚期胰头癌［J］.介入放射学杂志，2006，15（4）：247-248.
［17］ 宋恬，殷士蒙，孙荣跃，等.探讨介入治疗对晚期胰腺癌的疗效［J］.介入放射学杂志，2008，17（6）：411-413.
［18］ 刘凌晓，姬巍，王建华，等.胰腺癌肝转移患者综合性介入栓塞治疗生存情况的回顾性分析［J］.复旦学报（医学版），2011，38（2）：101-106.
［19］ 中华医学会放射学分会介入学组.胰腺癌经动脉灌注化疗指南（草案）［J］.介入放射学杂志，2012，21（5）：353-355.(https://www.daowen.com)
［20］ Japan Pancreas Society.Classification of pancreatic carcinoma［M］.2nd English ed.Tokyo：Kanehara &Co.Ltd.，2003.
［21］ Philip PA，Benedetti J，Corless CL，et al.PhaseⅢstudy comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma：Southwest Oncology Group directed intergroup trial S0205［J］.J Clin Oncol，2010，28：3605-3610.
［22］ Kindler HL，Niedzwiecki D，Hollis D，et al.Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer：phaseⅢtrial of the Cancer and Leukemia Group B（CALGB 80303）［J］.J Clin Oncol，2010，28：3617-3622.
［23］ Moore MJ，Goldstein D，Hamm J，et al.Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer：aphaseⅢtrial of the National Cancer Institute of Canada Clinical Trials Group［J］.J Clin Oncol，2007，25：1960-1966.
［24］ Tanaka T，Sakaguchi H，Sho M，et al.A novel interventional radiology technique for arterial infusion chemotherapy against advanced pancreatic Cancer［J］.AJR，2009，192（2）：168-177.
［25］ Conroy T，Desseigne F，Ychou M，et al.FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer［J］.New England Journal of Medicine，2011，364（19）：1817.
［26］ Kulke MH，Tempero MA，Niedzwiecki D，et al.Randomized phaseⅡstudy of gemcitabine administered at a fixed dose rate or in combination with cisplatin，docetaxel，or irinotecan in patients with metastatic pancreatic cancer：CALGB 89904［J］.J Clin Oncol，2009，27：5506-5512.
［27］ Cunningham D，Chau I，Stocken DD，et al.Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer［J］.J Clin Oncol，2009，27：5513-5518.
［28］ Louvet C.Gemcitabine in Combination With oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer：results of a GERCOR and GISCAD phaseⅢtrial［J］.Journal of Clinical Oncology，2005，23（15）：3509-3516.
［29］ Oettle H，Richards D，Ramanathan RK，et al.A phaseⅢtrial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer［J］.Ann Oncol，2005，16：1639-1645.
［30］ Abou-Alfa GK，Letourneau R，Harker G，et al.Randomized phaseⅢstudy of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer［J］.J Clin Oncol，2006，24：4441-4447.
［31］ Tempero M，Plunkett W，Ruiz Van Haperen V，et al.Randomized phaseⅡcomparison of doseintense gemcitabine：thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma［J］.J Clin Oncol，2003，21：3402-3408.
［32］ Menon KV，Gomez D，Smith AM，et al.Impact of margin status on survival following pancreatoduodenectomy for cancer：the Leeds Pathology Protocol（LEEPP）［J］.HPB（Oxford），2009，11（1）：18-24.
［33］ Homma H，Niitsu Y.A new regional arterial infusion chemotherapy for patients with advanced pancreatic cancer［J］.Gan to Kagaku Ryoho Cancer &Chemotherapy，2002，29（3）：383.
［34］ Zheng YY，Tang CW，Xu YQ，et al.Hepatic arterial infusion chemotherapy reduced hepatic metastases from pancreatic cancer after pancreatectomy［J］.Hepatogastroenterology，2014，61（133）：1415-1420.
［35］ Yoshidome H，Shimizu H，Ohtsuka M，et al.Pancreaticoduodenetomy combined with hepatic artery resection following preoperative hepatic arterial embolization［J］.J Hepatobiliary Pancreat Sci，2014，21（12）：850-855.
［36］ Yamagami，Yoshimatsu T，Kajiwara R，et al.Arteriography after embolization before distal pancreatectomy with en bloc celiac axis resection［J］.Minim Invasive Ther Allied Technol，2015，24（6）：350-355.
［37］ Toguchi M，Tsurusaki M，Numoto I，et al.Utility of amplatzer vascular plug with preoperative common hepatic artery embolization for distal pancreatectomy with en bloc celiac axis resection［J］.Cardiovasc Intervent Radiol，2017，40（3）：445-449.
［38］ Tanaka T，Sho M，Nishiofuku H，et al.Unresectable pancreatic cancer：arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-doseⅣgemcitabine［J］.Am J Roentgenol，2012，198（6）：1445-1452.